Armstrong Advisory Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Armstrong Advisory Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.8K	Hold	70	–	–	﹤0.01%	830
2026 Q2	$2.94K	Hold	70	–	–	﹤0.01%	859
2026 Q1	$1.85K	Hold	70	–	–	﹤0.01%	880
2025 Q4	$2.03K	Buy	+70	New	+$2.1K	﹤0.01%	862
2023 Q2	–	Sell	-13	Closed	-$391	–	803
2023 Q1	$391	Hold	13	–	–	﹤0.01%	764
2022 Q4	$367	Buy	+13	New	+$413	﹤0.01%	790

Other funds holding ARKG

MFPI

Midwest Financial Partners Investments St. Cloud, Minnesota $260M AUM 10.89% 1-Year Est. Return

CFIM

Client First Investment Management West Bend, Wisconsin $210M AUM 50.85% 1-Year Est. Return

PRTG

Post Resch Tallon Group Pittsford, New York $146M AUM 18.19% 1-Year Est. Return

TAM

Titleist Asset Management San Antonio, Texas $1.55B AUM 13.34% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

MHR

Matthew Hamilton Rosenberg $558M AUM 12.28% 1-Year Est. Return

Armstrong Advisory Group's ARKG Position: Q3 2026 in Review

Armstrong Advisory Group held its ARK Genomic Revolution ETF (ARKG) position steady in Q3 2026 at 70 shares worth $3.8K. The position accounts for ﹤0.01% of the portfolio, ranked #830.

Armstrong Advisory Group first reported a position in ARKG in Q4 2022 and has held it in 6 quarters since. 8 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

Armstrong Advisory Group held 70 shares of ARK Genomic Revolution ETF worth $3.8K as of Q3 2026.
Armstrong Advisory Group left its ARK Genomic Revolution ETF share count unchanged in Q3 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #830 holding.
Armstrong Advisory Group first reported a position in ARK Genomic Revolution ETF in Q4 2022 and has held it in 6 quarters since.
8 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.